clinical trial data Archives - Market Exclusive

Home Tags Clinical trial data

Biotech Data Watch: Galectin Therapeutics Inc (NASDAQ:GALT) and Revance Therapeutics, Inc....

ME Contributor - December 6, 2017

Biotech Movers: Ocera Therapeutics, Inc. (NASDAQ:OCRX) and Alnylam Pharmaceuticals, Inc. (Nasdaq:...

ME Contributor - November 6, 2017

Biotech Movers: Stemline Therapeutics, Inc. (NASDAQ:STML) And Mylan N.V. (NASDAQ:MYL)

ME Contributor - November 1, 2017

Biotech Movers: Amicus Therapeutics, Inc. (NASDAQ:FOLD) And Vanda Pharmaceuticals Inc. (NASDAQ:VNDA)

ME Contributor - September 14, 2017

Esperion Therapeutics Inc (NASDAQ:ESPR): Get It While It’s Cheap

ME Contributor - March 20, 2017

Here’s What Happened With Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) and Nivalis Therapeutics...

ME Contributor - February 24, 2017

Delving Into Seattle Genetics, Inc. (NASDAQ:SGEN)’s Upcoming Readout

ME Contributor - July 28, 2016

What Medidur’s first success means for pSivida shareholders

Rafi Farber - December 22, 2015

Two Biotechs With Catalysts This Week

Roger Hannington - September 21, 2015

Biotech 101: How To Read Clinical Trial Data

Jennifer Aldershot - September 18, 2015

/* */

EDITOR PICKS

Cannabis Stock News Daily Roundup April 15

April 15, 2019

Canopy Growth Spectrum Cannabis Targets Canadians Seniors

April 15, 2019

Cannabis Stock News Daily Roundup April 12

April 12, 2019

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

ABOUT US

Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.

Tag: clinical trial data